COVID-19 and HIV: Clinical Outcomes among Hospitalized Patients in the United States

被引:0
|
作者
Faiz, Zohaa [1 ]
Quazi, Mohammed A. [2 ]
Vahil, Neel [3 ]
Barrows, Charles M. [3 ]
Ikram, Hafiz Abdullah [3 ]
Nasrullah, Adeel [4 ]
Farooq, Asif [5 ]
Gangu, Karthik [6 ]
Sheikh, Abu Baker [3 ]
机构
[1] Aga Khan Univ, Sch Med, Dept Med, Karachi 74000, Pakistan
[2] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87106 USA
[3] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87106 USA
[4] Allegheny Hlth Network, Div Pulmonol & Crit Care, Pittsburgh, PA 15212 USA
[5] Texas Tech Hlth Sci Ctr, Dept Family & Community Med, Lubbock, TX 79409 USA
[6] Univ Kansas Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA
基金
美国医疗保健研究与质量局;
关键词
COVID-19; HIV; mortality; prevalence; complications; United States; National Inpatient Sample; CORONAVIRUS DISEASE 2019; MORTALITY; INFECTION; PEOPLE; COHORT; DEATH;
D O I
10.3390/biomedicines11071904
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concurrence of HIV and COVID-19 yields unique challenges and considerations for healthcare providers, patients living with HIV, and healthcare systems at-large. Persons living with HIV may face a higher risk of acquiring SARS-CoV-2 infection and experiencing worse clinical outcomes compared to those without. Notably, COVID-19 may have a disproportionate impact on historically disadvantaged populations, including African Americans and those stratified in a lower socio-economic status. Using the National Inpatient Sample (NIS) database, we compared patients with a diagnosis of both HIV and COVID-19 and those who exclusively had a diagnosis of COVID-19. The primary outcome was in-hospital mortality. Secondary outcomes were intubation rate and vasopressor use; acute MI, acute kidney injury (AKI); AKI requiring hemodialysis (HD); venous thromboembolism (VTE); septic shock and cardiac arrest; length of stay; financial burden on healthcare; and resource utilization. A total of 1,572,815 patients were included in this study; a COVID-19-positive sample that did not have HIV (n = 1,564,875, 99.4%) and another sample with HIV and COVID-19 (n = 7940, 0.56%). Patients with COVID-19 and HIV did not have a significant difference in mortality compared to COVID-19 alone (10.2% vs. 11.3%, respectively, p = 0.35); however, that patient cohort did have a significantly higher rate of AKI (33.6% vs. 28.6%, aOR: 1.26 [95% CI 1.13-1.41], p < 0.001). Given the complex interplay between HIV and COVID-19, more prospective studies investigating the factors such as the contribution of viral burden, CD4 cell count, and the details of patients' anti-retroviral therapeutic regimens should be pursued.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Natriuretic Peptide Levels and Clinical Outcomes among Patients Hospitalized with COVID-19 Infection
    Aslam, M. I.
    Minhas, A.
    Ghorbani, A.
    Shade, J.
    Jani, V.
    Hsu, S.
    Sharma, K.
    Cihakova, D.
    Hays, A.
    Gilotra, N. A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S210 - S210
  • [22] Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19
    Barrett, Brendan
    Pamphile, Styve
    Yang, Fan
    Naeem, Farnia
    Kim, Jinsung
    Annam, Jayabhargav
    Borczuk, Rachel
    Yellin, Shira
    Bass, Carly
    Fowler, Sabrina
    Mosheyev, Maykl
    Mayer, Yael Jessica
    Friedman, Benjamin W.
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 46 : 595 - 598
  • [23] The prevalence of hyperkalemia and associated clinical characteristics and outcomes among hospitalized COVID-19 patients
    Agiro, Abiy
    Moon, Rena
    Rosenthal, Ning
    Brown, Harold
    Legg, Randall
    Amin, Alpesh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 106 - 106
  • [24] ASSOCIATION OF DEMENTIA AND OUTCOMES AMONG HOSPITALIZED COVID-19 PATIENTS
    Vekaria, Pratikkumar
    Syed, Areej
    Anderson, Jeffrey
    Cornett, Brendon
    Bourbia, Amine
    Flynn, Michael
    Kashyap, Rahul
    Shah, Asif
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 131 - 131
  • [25] Probiotics use is associated with improved clinical outcomes among hospitalized patients with COVID-19
    Zhang, Lina
    Han, Huanqin
    Li, Xuan
    Chen, Caozhen
    Xie, Xiaobing
    Su, Guomei
    Ye, Shicai
    Wang, Cuili
    He, Qing
    Wang, Fang
    Huang, Fang
    Wang, Zhaoqin
    Wu, Jiayuan
    Lai, Tianwen
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [26] Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
    Bhatt, Ankeet S.
    Jering, Karola S.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Cunningham, Jonathan W.
    Rosenthal, Ning
    Signorovitch, James
    Thune, Jens J.
    Vardeny, Orly
    Solomon, Scott D.
    [J]. JACC-HEART FAILURE, 2021, 9 (01) : 65 - 73
  • [27] Association of renalase with clinical outcomes in hospitalized patients with COVID-19
    Safdar, Basmah
    Wang, Melinda
    Guo, Xiaojia
    Cha, Charles
    Chun, Hyung J.
    Deng, Yanhong
    Dziura, James
    El-Khoury, Joe M.
    Gorelick, Fred
    Ko, Albert, I
    Lee, Alfred, I
    Safirstein, Robert
    Simonov, Michael
    Zhou, Bin
    Desir, Gary, V
    [J]. PLOS ONE, 2022, 17 (03):
  • [28] Effects of statins on clinical outcomes in hospitalized patients with COVID-19
    Martins-Filho, Paulo Ricardo
    Soares Barreto-Filho, Jose Augusto
    Sobral Sousa, Antonio Carlos
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 104 : 113 - 115
  • [29] Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD
    Turan, Onur
    Yigitbas, Burcu Arpinar
    Turan, Pakize Ayse
    Mirici, Arzu
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (08) : 1069 - 1076
  • [30] Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
    Turan, Muzaffer Onur
    Yigitbas, Burcu Arpinar
    Turan, Pakize Ayse
    Mirici, Arzu
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58